Structural characterization of an LPA1 second extracellular loop mimetic with a self-assembling coiled-coil folding constraint

International Journal of Molecular Sciences

Volumn 14, Issue 2, 2013, Pages 2788-2807

  Young, John K ^a,b   Clayton, Benjamin T ^a   Kikonyogo, Alexandra ^a   Pham, Truc Chi T ^a   Parrill, Abby L ^a  

^a University of Memphis   (United States)

^b CHRISTIAN BROTHERS UNIVERSITY   (United States)

Author keywords

G protein coupled receptor; GPCR; GPCR segment model; LPA; Lysophosphatidic acid; NMR

Indexed keywords

G PROTEIN COUPLED RECEPTOR; LPA1 CC EL2 PEPTIDE; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID 1; LYSOPHOSPHATIDIC ACID 1 RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR; PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; EXTRACELLULAR LOOP; MATHEMATICAL MODEL; MOLECULAR DOCKING; NUCLEAR MAGNETIC RESONANCE; PROTEIN ASSEMBLY; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS;

EID: 84875103206     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14022788     Document Type: Article

References (47)

1. Lundstrom, K. Latest development in drug discovery on G protein-coupled receptors. Curr. Protein Pept. Sci. 2006, 7, 465-470.
2. Esbenshade, T.A. G protein-coupled receptors as targets for drug discovery. Drug Discov. Series 2006, 4, 15-36.
3. Herr, D.R.; Chun, J. Effects of LPA and S1P on the nervous system and implications for their involvement in disease. Curr. Drug Targets 2007, 8, 155-167.
4. Murph, M.; Mills, G.B. Targeting the lipids LPA and S1P and their signalling pathways to inhibit tumour progression. Expert Rev. Mol. Med. 2007, 9, 1-18.
5. Pua, T.L.; Wang, F.Q.; Fishman, D.A. Roles of LPA in ovarian cancer development and progression. Future Oncol. 2009, 5, 1659-1673.
6. Shida, D.; Kitayama, J.; Yamaguchi, H.; Okaji, Y.; Tsuno, N.H.; Watanabe, T.; Takuwa, Y.; Nagawa, H. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res. 2003, 63, 1706-1711.
7. Hama, K.; Aoki, J.; Fukaya, M.; Kishi, Y.; Sakai, T.; Suzuki, R.; Ohta, H.; Yamori, T.; Watanabe, M.; Chun, J.; et al. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J. Biol. Chem. 2004, 279, 17634-17639.
8. Kishi, Y.; Okudaira, S.; Tanaka, M.; Hama, K.; Shida, D.; Kitayama, J.; Yamori, T.; Aoki, J.; Fujimaki, T.; Arai, H. Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid. J. Biol. Chem. 2006, 281, 17492-17500.
9. Wang, D.; Lorincz, Z.; Bautista, D.L.; Liliom, K.; Tigyi, G.; Parrill, A.L. A Single Amino Acid Determines Ligand Specificity of the S1P1 (EDG1) and LPA1 (EDG2) Phospholipid Growth Factor Receptors. J. Biol. Chem. 2001, 276, 49213-49220.
10. Sardar, V.M.; Bautista, D.L.; Fischer, D.J.; Yokoyama, K.; Nusser, N.; Virag, T.; Wang, D.; Baker, D.L.; Tigyi, G.; Parrill, A.L. Molecular Basis for Lysophosphatidic Acid Receptor Antagonist Selectivity. Biochim. Biophys. Acta 2002, 1582, 309-317.
11. Virag, T.; Elrod, D.B.; Liliom, K.; Sardar, V.M.; Parrill, A.L.; Yokoyama, K.; Durgam, G.; Deng, W.; Miller, D.D.; Tigyi, G. Fatty Alcohol Phosphates are Subtype-Selective Agonists and Antagonists of LPA Receptors. Mol. Pharmacol. 2003, 63, 1032-1042.
12. Valentine, W.J.; Fells, J.I.; Perygin, D.H.; Mujahid, S.; Yokoyama, K.; Fujiwara, Y.; Tsukahara, R.; van Brocklyn, J.R.; Parrill, A.L.; Tigyi, G. Subtype-specific residues involved in ligand activation of the endothelial differentiation gene family lysophosphatidic acid receptors. J. Biol. Chem. 2008, 283, 12175-12187.
13. Zhang, H.; Xu, X.; Gajewiak, J.; Tsukahara, R.; Fujiwara, Y.; Liu, J.; Fells, J.I.; Perygin, D.; Parrill, A.L.; Tigyi, G.; et al. Dual activity lysophosphatidic acid receptor pan-antagonist/autotaxin inhibitor reduces breast cancer cell migration in vitro and causes tumor regression in vivo. Cancer Res. 2009, 69, 5441-5449.
14. Shimamura, T.; Shiroishi, M.; Weyand, S.; Tsujimoto, H.; Winter, G.; Katritch, V.; Abagyan, R.; Cherezov, V.; Liu, W.; Han, G.W.; et al. Structure of the human histamine H1 receptor complex with doxepin. Nature 2011, 475, 65-70.
15. Chien, E.Y.; Liu, W.; Zhao, Q.; Katritch, V.; Han, G.W.; Hanson, M.A.; Shi, L.; Newman, A.H.; Javitch, J.A.; Cherezov, V.; et al. Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science 2010, 330, 1091-1095.
16. Wu, B.; Chien, E.Y.; Mol, C.D.; Fenalti, G.; Liu, W.; Katritch, V.; Abagyan, R.; Brooun, A.; Wells, P.; Bi, F.C.; et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 2010, 330, 1066-1071.
17. Jaakola, V.P.; Griffith, M.T.; Hanson, M.A.; Cherezov, V.; Chien, E.Y.; Lane, J.R.; Ijzerman, A.P.; Stevens, R.C. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 2008, 322, 1211-1217.
18. Warne, T.; Serrano-Vega, M.J.; Baker, J.G.; Moukhametzianov, R.; Edwards, P.C.; Henderson, R.; Leslie, A.G.; Tate, C.G.; Schertler, G.F. Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 2008, 454, 486-491.
19. Cherezov, V.; Rosenbaum, D.M.; Hanson, M.A.; Rasmussen, S.G.; Thian, F.S.; Kobilka, T.S.; Choi, H.J.; Kuhn, P.; Weis, W.I.; Kobilka, B.K.; et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007, 318, 1258-1265.
20. Rasmussen, S.G.; Choi, H.J.; Rosenbaum, D.M.; Kobilka, T.S.; Thian, F.S.; Edwards, P.C.; Burghammer, M.; Ratnala, V.R.; Sanishvili, R.; Fischetti, R.F.; et al. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 2007, 450, 383-387.
21. Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C.A.; Motoshima, H.; Fox, B.A.; Le Trong, I.; Teller, D.C.; Okada, T.; Stenkamp, R.; et al. Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor. Science 2000, 289, 739-745.
22. Haga, K.; Kruse, A.C.; Asada, H.; Yurugi-Kobayashi, T.; Shiroishi, M.; Zhang, C.; Weis, W.I.; Okada, T.; Kobilka, B.K.; Haga, T.; et al. Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist. Nature 2012, 482, 547-551.
23. Wu, H.; Wacker, D.; Mileni, M.; Katritch, V.; Han, G.W.; Vardy, E.; Liu, W.; Thompson, A.A.; Huang, X.P.; Carroll, F.I.; et al. Structure of the human kappa-opioid receptor in complex with JDTic. Nature 2012, 485, 327-332.
24. Manglik, A.; Kruse, A.C.; Kobilka, T.S.; Thian, F.S.; Mathiesen, J.M.; Sunahara, R.K.; Pardo, L.; Weis, W.I.; Kobilka, B.K.; Granier, S. Crystal structure of the micro-opioid receptor bound to a morphinan antagonist. Nature 2012, 485, 321-326.
25. Hanson, M.A.; Roth, C.B.; Jo, E.; Griffith, M.T.; Scott, F.L.; Reinhart, G.; Desale, H.; Clemons, B.; Cahalan, S.M.; Schuerer, S.C.; et al. Crystal structure of a lipid G protein-coupled receptor. Science 2012, 335, 851-855.
26. Granier, S.; Manglik, A.; Kruse, A.C.; Kobilka, T.S.; Thian, F.S.; Weis, W.I.; Kobilka, B.K. Structure of the delta-opioid receptor bound to naltrindole. Nature 2012, 485, 400-404.
27. Thompson, A.A.; Liu, W.; Chun, E.; Katritch, V.; Wu, H.; Vardy, E.; Huang, X.P.; Trapella, C.; Guerrini, R.; Calo, G.; et al. Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic. Nature 2012, 485, 395-399.
28. Park, S.H.; Casagrande, F.; Chu, M.; Maier, K.; Kiefer, H.; Opella, S.J. Optimization of purification and refolding of the human chemokine receptor CXCR1 improves the stability of proteoliposomes for structure determination. Biochim. Biophys. Acta 2012, 1818, 584-591.
29. Park, S.H.; Das, B.B.; Casagrande, F.; Tian, Y.; Nothnagel, H.J.; Chu, M.; Kiefer, H.; Maier, K.; de Angelis, A.A.; Marassi, F.M.; et al. Structure of the chemokine receptor CXCR1 in phospholipid bilayers. Nature 2012, 491, 779-783.
30. Parrill, A.L.; Bautista, D.L. GPCR Conformations: Implications for Rational Drug Design. Pharmaceuticals 2011, 4, 7-43.
31. Pham, T.T.; Kriwacki, R.W.; Parrill, A.L. Peptide Design and Structural Characterization of a GPCR Loop Mimetic. Biopolymers 2007, 86, 298-310.
32. Oakley, M.G.; Kim, P.S. A buried polar interaction can direct the relative orientation of helices in a coiled coil. Biochemistry 1998, 37, 12603-12610.
33. Kruse, A.C.; Hu, J.; Pan, A.C.; Arlow, D.H.; Rosenbaum, D.M.; Rosemond, E.; Green, H.F.; Liu, T.; Chae, P.S.; Dror, R.O.; et al. Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nature 2012, 482, 552-556.
34. Janes, R.W. Reference Datasets for Circular Dichroism and Synchrotron Radiation Circular Dichroism Spectroscopy of Proteins. In Advances in Biomedical Spectrscopy; Wallace, B.A., Janes, R.W., Eds.; IOS Press: Fairfax, VA, USA, 2008; Volume 1.
35. Lobley, A.; Whitmore, L.; Wallace, B.A. DICHROWEB: An interactive website for the analysis of protein secondary structure from circular dichroism spectra. Bioinformatics 2002, 18, 211-212.
36. Whitmore, L.; Wallace, B.A. DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res. 2004, 32, W668-W673.
37. Whitmore, L.; Wallace, B.A. Protein Secondary Structure Analyses from Circular Dichroism Spectroscopy: Methods and Reference Databases. Biopolymers 2008, 89, 392-400.
38. Parrill, A.L.; Tigyi, G. Integrating the puzzle pieces: The current atomistic picture of phospholipid-G protein coupled receptor interactions. Biochim. Biophys. Acta 2013, 1831, doi:10.1016/j.bbalip.2012.09.002.
39. Luthra, A.; Malik, S.S.; Ramachandran, R. Cloning, purification and comparative structural analysis of two hypothetical proteins from Mycobacterium tuberculosis found in the human granuloma during persistence and highly up-regulated under carbon-starvation conditions. Protein Expr. Purif. 2008, 62, 64-74.
40. Delaglio, F.; Grzesiek, S.; Vuister, G.W.; Zhu, G.; Pfeifer, J.; Bax, A. NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 1995, 6, 277-293.
41. Garrett, D.S.; Powers, R.; Gronenborn, A.M.; Clore, G.M. A Common-Sense Approach to Peak Picking in 2-Dimensional, 3-Dimensional, and 4-Dimensional Spectra Using Automatic Computer-Analysis of Contour Diagrams. J. Magn. Resonance 1991, 95, 214-220.
42. Cornilescu, G.; Delaglio, F.; Bax, A. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR 1999, 13, 289-302.
43. Brunger, A.T.; Adams, P.D.; Clore, G.M.; DeLano, W.L.; Gros, P.; Grosse-Kunstleve, R.W.; Jiang, J.S.; Kuszewski, J.; Nilges, M.; Pannu, N.S.; et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. D 1998, 54, 905-921.
44. Fujiwara, Y.; Sardar, V.; Tokumura, A.; Baker, D.; Murakami-Murofushi, K.; Parrill, A.; Tigyi, G. Identification of residues responsible for ligand recognition and regioisomeric selectivity of lysophosphatidic acid receptors expressed in mammalian cells. J. Biol. Chem. 2005, 280, 35038-35050.
45. MOE, 2010.12; Chemical Computing Group: Montreal, Canada, 2010.
46. Fells, J.I.; Tsukahara, R.; Fujiwara, Y.; Liu, J.; Perygin, D.H.; Osborne, D.A.; Tigyi, G.; Parrill, A.L. Identification of non-lipid LPA3 antagonists by virtual screening. Bioorg. Med. Chem. 2008, 16, 6207-6217.
47. Fells, J.I.; Tsukahara, R.; Liu, J.; Tigyi, G.; Parrill, A.L. Structure-based drug design identifies novel LPA3 antagonists. Bioorg. Med. Chem. 2009, 17, 7457-7464.